Charles River Laboratories (CRL) Tops Q4 EPS by 9c, Revenues Beat; Offers FY19 EPS Mid-Point Guidance Below Consensus
Go back to Charles River Laboratories (CRL) Tops Q4 EPS by 9c, Revenues Beat; Offers FY19 EPS Mid-Point Guidance Below Consensus| CHARLES RIVER LABORATORIE (NYSE: CRL) | Delayed: 279.01 +0.95 (0.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $278.06 | 52 Week High | $89.18 | |||
| Open | $279.37 | 52 Week Low | $65.70 | |||
| Day High | $281.63 | P/E | 129.77 | |||
| Day Low | $275.88 | EPS | $2.15 | |||
| Volume | 952,919 | |||||
